Mr. Carlisle has more than 17 years of experience in the medical device industry, according to a July 22 news release. He previously worked with Integra LifeSciences and Perma Pure. He also held a position on NovaBone’s board of directors for 10 months.
NovaBone is based in Alachua, Fla., and is behind the first orthopedic bioactive synthetic bone graft, according to the company.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
